Targeting the miR-577/CHEK2/FOXM1 axis, LINC01094 promotes radioresistance in clear cell renal cell carcinoma (ccRCC) (Jiang et al., 2020). Here, CHEK2 is linked to nonpapillary renal cell carcinoma.